The inhibition of DAPK1 might also be an effective therapy for advanced endometrial adenocarcinomas and acute brain injury by hypoxia–ischemia, but the relevance of DAPK1 to those diseases is still under study (Tanaka et al., 2010 ▸; Velentza et al., 2003 ▸). This evidence concerns the gene DAPK1 and endometrium adenocarcinoma.